Jscholar Scientific Communications is hosting scientific event WCTO-2020 at Biltmore Hotel & Suites Santa Clara Hotel, CA, U.S.A during November 23-25, 2020 and we honored to welcome academic scientists, research scholars, professor, doctors, working professionals and enthusiastic personalities in the field of cancer science research.
Jscholar Scientific Communications is the modern and innovative scientific journal publisher and event organizer since 2013. It’s been publishing various medical, clinical and engineering Journals and conducting events with the association of hundreds of highly qualified editorial board members from different countries.
WCTO-2020 is the international conference aims to provide scientific platform to explore different aspects of research work from various countries to the wide range of audience and working professionals.
These three days gathering consists of keynote forums, Plenary sessions and interactive workshops & poster presentations, Exhibitions, group discussions with Renowned Speakers from across the globe.
All abstracts will be published in conference proceedings and will be assigned with DOI number by submitting to Corssref.
As there is an advancement in cancer treatment and therapy and as world class researchers are following different aspects and strategies for the treatment of cancer, there is a necessity to learn and focus on current trends in our research interest community. WCTO-2020 is best opportunity to reach largest number of participants of the cancer science research professionals, Noble Laureates, academicians, industrialist to share ideas and interact with each other. WCTO-2020 a is a perfect organization for important new ideas, interesting lectures and fruitful discussions, to share your experience to the future world by your presence.
Cancer Clinical Trials
Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, a newly-inverted nipple, or a red or scaly patch of skin. In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin. Risk factors for developing breast cancer include being female, obesity, lack of physical exercise, drinking alcohol, hormone replacement therapy during menopause, ionizing radiation, early age at first menstruation, having children late or not at all, older age, prior history of breast cancer, and family history.
Clinical trials for cancer are research studies that compare the most effective known treatment for a specific type or stage of cancer with a new approach. This can be a new drug, or combination of drugs or a different way of using established therapies. There are trials that involve new approaches to surgery and radiation therapy. There are clinical trials for every type of cancer. While many trials focus on late stage disease, there are also trials to prevent cancer, improve early diagnosis, stop the cancer from coming back, reduce side effects or improve quality of life.
Computational oncology is a generic term that encompasses any form of computer-based modelling relating to tumour biology and cancer therapy. Mathematical modelling can be used to probe the pharmacokinetics and pharmacodynamics relationships of the available anticancer agents in order to improve treatment. Computational Oncology is a semi-new phrase that is beginning to gain speed in medicine. It may be surprising to some to find out that there are full departments being created at large medical institutions across the globe titled as such.
Gynecologic cancer is an uncontrolled growth and spread of abnormal cells that originate from the reproductive organs. There are several types of gynecologic cancers which include cervical, gestational trophoblastic disease (GTD), primary peritoneal, ovarian, uterine/endometrial, vaginal and vulvar cancers. Gynecologic cancer is any cancer that starts in a woman's reproductive organs. Five main types of cancer affect a woman's reproductive organs are cervical, ovarian, uterine, vaginal and vulvar. As a group, they are referred to as gynecologic cancer. A sixth type of gynecologic cancer is the very rare fallopian tube cancer.
Radiation therapy or radiotherapy, often abbreviated RT, RTx, or XRT, is therapy using ionizing radiation, generally as part of cancer treatment to control or kill malignant cells and normally delivered by a linear accelerator. Radiation therapy may be curative in a number of types of cancer if they are localized to one area of the body. It may also be used as part of adjuvant therapy, to prevent tumor recurrence after surgery to remove a primary malignant tumor (for example, early stages of breast cancer). Radiation therapy is synergistic with chemotherapy, and has been used before, during, and after chemotherapy in susceptible cancers.
Sarcoma is a cancer that arises from transformed cells of mesenchymal (connective tissue) origin. Connective tissue is a broad term that includes bone, cartilage, fat, vascular, or hematopoietic tissues, and sarcomas can arise in any of these types of tissues. As a result, there are many subtypes of sarcoma, which are classified based on the specific tissue and type of cell from which the tumor originates. It is important to note that sarcomas are primary connective tissue tumors, meaning that they arise in connective tissues. This is in contrast to secondary (or "metastatic") connective tissue tumors, which occur when a cancer from elsewhere in the body (such as the lungs, breast tissue or prostate) spreads to the connective tissue.
Organizing Committee Members